EGV1.1 SELF MONITORING BLOOD GLUCOSE SYSTEM AND EGV1.1 PRO MONITORING BLOOD GLUCOSE SYSTEM— 510(k) K133537

Substantially Equivalent

Eps Bio Technology Corp.

FDA 510(k) clearance K133537 for EGV1.1 SELF MONITORING BLOOD GLUCOSE SYSTEM AND EGV1.1 PRO MONITORING BLOOD GLUCOSE SYSTEM, Substantially Equivalent on 2014-04-28. Applicant: Eps Bio Technology Corp..

Clearance details

Applicant: Eps Bio Technology Corp.
Product code: Code LFR
Advisory panel: Clinical Chemistry
Date received: 2013-11-18
Decision date: 2014-04-28
Decision: Substantially Equivalent
Clearance type: Special
Location: Hsinchu, TW

Download summary PDF View on FDA.gov ↗

Adverse events under product code LFR

product code LFR

Death: 3
Malfunction: 1,634
Total: 1,637

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.